Cardiotoxicity of immune checkpoint inhibitors: An updated review-Reference-Cited by-同舟云学术

Cardiotoxicity of immune checkpoint inhibitors: An updated review

Published:2020-12-09 Issue: Volume: Page:
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Behravesh Soheil¹,Shomali Navid²^ORCID,Danbaran Gholamreza Rezaei¹,Aslani Saeed³,Hemmatzadeh Maryam²,Hosseinzadeh Ramin³,Gowhari‐Shabgah Arezoo⁴,Mohammadi Hamed⁵⁶^ORCID

Affiliation:

1. Student Research Committee Shahid Sadoughi University of Medical Sciences Yazd Iran

2. Student Research Committee Tabriz University of Medical Sciences Tabriz Iran

3. Department of Medical Immunology School of Medicine Tehran University of Medical Sciences Tehran Iran

4. School of Medicine Bam University of Medical Sciences Bam Iran

5. Non‐Communicable Diseases Research Center Alborz University of Medical Sciences Karaj Iran

6. Department of Immunology School of Medicine Alborz University of Medical Sciences Karaj Iran

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bab.2081

Reference102 articles.

1. Immune checkpoint receptors in regulating immune reactivity in rheumatic disease

2. Cancer immunotherapy comes of age

3. Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates in the therapeutic uses of Pembrolizumab: a brief narrative review;Clinical and Translational Oncology;2024-04-24

2. Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography;Frontiers in Cardiovascular Medicine;2022-12-21

3. Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis;Frontiers in Immunology;2022-07-08

4. Towards exertion of immunotherapeutics in the treatment of colorectal cancer; adverse sides, challenges, and future directions;International Immunopharmacology;2021-12

5. Human Organoids for Predictive Toxicology Research and Drug Development;Frontiers in Genetics;2021-11-01